Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Carlyle (CGABL) EBT (2016 - 2025)

Carlyle has reported EBT over the past 15 years, most recently at $461.8 million for Q4 2025.

  • Quarterly results put EBT at $461.8 million for Q4 2025, up 74.0% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (down 16.83% YoY), and the annual figure for FY2025 was $1.2 billion, down 16.83%.
  • EBT for Q4 2025 was $461.8 million at Carlyle, up from $85.8 million in the prior quarter.
  • Over the last five years, EBT for CGABL hit a ceiling of $1.3 billion in Q2 2021 and a floor of -$842.7 million in Q4 2023.
  • Median EBT over the past 5 years was $282.6 million (2022), compared with a mean of $377.6 million.
  • Biggest five-year swings in EBT: tumbled 591.37% in 2023 and later soared 418.27% in 2024.
  • Carlyle's EBT stood at $909.2 million in 2021, then crashed by 81.14% to $171.5 million in 2022, then tumbled by 591.37% to -$842.7 million in 2023, then soared by 131.49% to $265.4 million in 2024, then soared by 74.0% to $461.8 million in 2025.
  • The last three reported values for EBT were $461.8 million (Q4 2025), $85.8 million (Q3 2025), and $440.6 million (Q2 2025) per Business Quant data.